全文获取类型
收费全文 | 1004159篇 |
免费 | 69995篇 |
国内免费 | 2588篇 |
专业分类
耳鼻咽喉 | 13016篇 |
儿科学 | 34475篇 |
妇产科学 | 28460篇 |
基础医学 | 145351篇 |
口腔科学 | 27745篇 |
临床医学 | 90421篇 |
内科学 | 193968篇 |
皮肤病学 | 22929篇 |
神经病学 | 79310篇 |
特种医学 | 38418篇 |
外国民族医学 | 305篇 |
外科学 | 149576篇 |
综合类 | 23742篇 |
一般理论 | 385篇 |
预防医学 | 77893篇 |
眼科学 | 22647篇 |
药学 | 71984篇 |
19篇 | |
中国医学 | 2034篇 |
肿瘤学 | 54064篇 |
出版年
2018年 | 10586篇 |
2017年 | 8269篇 |
2016年 | 9382篇 |
2015年 | 10600篇 |
2014年 | 14425篇 |
2013年 | 22000篇 |
2012年 | 28981篇 |
2011年 | 30824篇 |
2010年 | 18487篇 |
2009年 | 17435篇 |
2008年 | 28786篇 |
2007年 | 30459篇 |
2006年 | 30959篇 |
2005年 | 29637篇 |
2004年 | 28924篇 |
2003年 | 27796篇 |
2002年 | 26812篇 |
2001年 | 46923篇 |
2000年 | 48032篇 |
1999年 | 40262篇 |
1998年 | 11177篇 |
1997年 | 10095篇 |
1996年 | 10160篇 |
1995年 | 9775篇 |
1994年 | 9090篇 |
1993年 | 8480篇 |
1992年 | 32248篇 |
1991年 | 31458篇 |
1990年 | 31006篇 |
1989年 | 29874篇 |
1988年 | 27167篇 |
1987年 | 27325篇 |
1986年 | 25434篇 |
1985年 | 24601篇 |
1984年 | 18397篇 |
1983年 | 15515篇 |
1982年 | 9288篇 |
1981年 | 8375篇 |
1979年 | 16859篇 |
1978年 | 12217篇 |
1977年 | 10314篇 |
1976年 | 9754篇 |
1975年 | 10178篇 |
1974年 | 12317篇 |
1973年 | 11843篇 |
1972年 | 10884篇 |
1971年 | 10113篇 |
1970年 | 9375篇 |
1969年 | 8724篇 |
1968年 | 8104篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Swann Arp Adams Catherine L. Rohweder Jennifer Leeman Daniela B. Friedman Ziya Gizlice Robin C. Vanderpool Natoshia Askelson Alicia Best Susan A. Flocke Karen Glanz Linda K. Ko Michelle Kegler 《Journal of community health》2018,43(6):1044-1052
While colorectal cancer (CRC) screening rates have been increasing in the general population, rates are considerably lower in Federally Qualified Health Centers (FQHCs), which serve a large proportion of uninsured and medically vulnerable patients. Efforts to screen eligible patients must be accelerated if we are to reach the national screening goal of 80% by 2018 and beyond. To inform this work, we conducted a survey of key informants at FQHCs in eight states to determine which evidence-based interventions (EBIs) to promote CRC screening are currently being used, and which implementation strategies are being employed to ensure that the interventions are executed as intended. One hundred and forty-eight FQHCs were invited to participate in the study, and 56 completed surveys were received for a response rate of 38%. Results demonstrated that provider reminder and recall systems were the most commonly used EBIs (44.6%) while the most commonly used implementation strategy was the identification of barriers (84.0%). The mean number of EBIs that were fully implemented at the centers was 2.4 (range 0–7) out of seven. Almost one-quarter of respondents indicated that their FQHCs were not using any EBIs to increase CRC screening. Full implementation of EBIs was correlated with higher CRC screening rates. These findings identify gaps as well as the preferences and needs of FQHCs in selecting and implementing EBIs for CRC screening. 相似文献
52.
53.
54.
55.
56.
M. Barro B. Sanogo A.S. Ouermi B.R. Zio A.B.I. Ouattara B. Nacro 《Revue d'épidémiologie et de santé publique》2018,66(6):363-367
Background
In order to contribute to the fight against the pediatric HIV infection, we have assessed, through a study in which we have systematically proposed to carry out children's testing, the rate of acceptability and the feasibility of children's HIV testing during the routine activities of the department. We have also analyzed the reasons for the acceptability or the refusal of the child's HIV testing by the accompanying person.Methods
The study took place from May to September 2015 including all the parents/legal guardians of any child aged 0 to 14 years coming for a consultation or who was hospitalized in the Pediatric Department of Souro Sanou Teaching Hospital. Counseling sessions conducted by community health workers focused on informing and proposing the principle of child testing. After obtaining the verbal and informed consent of the accompanying person, the first test was performed with Determine® by a hospital health worker. A second SD Bioline®/ImmunoCombII® test was performed if the first test was positive. With children aged less than 18 months, after a positive antibody test, we resorted to PCR for confirmation.Results
A total of 848 accompanying persons, 568 of whom were female, underwent a pre-test interview during which the HIV test was offered to them. The mean age of accompanying persons was 30 (25.5 to 38) years; 747 accompanying persons (88.1%) accepted the testing of their child. We have found an influence of the accompanying person's religion (P = 0.02) and the type of accompanying person on the acceptability of children's testing. Mothers were more willing to accept the test compared to other accompanying persons (P = 0.002). The main reason for refusing the child's testing was the absence of one of the child's parents, mainly the father whose opinion was needed. The test was positive for HIV1 in 10 children.Conclusion
In health centers, getting the informed consent from parents to test their children is a big challenge. However, our study shows that this is possible, through the high rate of acceptability obtained. 相似文献57.
58.
Valerii E. Orel Marina Tselepi Thanos Mitrelias Alexander Rykhalskyi Andriy Romanov Valerii B. Orel Anatoliy Shevchenko Anatoliy Burlaka Sergey Lukin Crispin H.W. Barnes 《Nanomedicine : nanotechnology, biology, and medicine》2018,14(4):1249-1256
Modulation of reactive oxygen and nitrogen species in a tumor could be exploited for nanotherapeutic benefits. We investigate the antitumor effect in Walker-256 carcinosarcoma of magnetic nanodots composed of doxorubicin-loaded Fe3O4 nanoparticles combined with electromagnetic fields. Treatment using the magnetic nanodot with the largest hysteresis loop area (3402 erg/g) had the greatest antitumor effect with the minimum growth factor 0.49 ± 0.02 day–1 (compared to 0.58 ± 0.02 day–1 for conventional doxorubicin). Electron spin resonance spectra of Walker-256 carcinosarcoma treated with the nanodots, indicate an increase of 2.7 times of free iron (that promotes the formation of highly reactive oxygen species), using the nanodot with the largest hysteresis loop area, compared to conventional doxorubicin treatment as well as increases in ubisemiquinone, lactoferrin, NO-FeS-proteins. Hence, we provide evidence that the designed magnetic nanodots can modulate the tumor redox state. We discuss the implications of these results for cancer nanotherapy. 相似文献
59.
60.